PRELIVE: A Framework for Predicting Lipid Nanoparticles In Vivo Efficacy and Reducing Reliance on Animal Testing
- Journal:
- Advanced Functional Materials
- Published:
- Affiliations:
- 2
- Authors:
- 4
| Institutions | Authors | Share |
|---|---|---|
| AstraZeneca Sweden, Sweden | 0.75 | |
| AstraZeneca, United Kingdom (UK) | 0.25 |